[JANX] YoY Quarter Result on 30-Sep-2020 [#Q3]

Stock
[JANX] Janux Therapeutics, Inc.
Announcement Date
29-Sep-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 48.94%
YoY-
Quarter Report
JANX's Result
JANX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
Revenue 439 2,517 1,813 1,159 0 -
PBT -28,059 -11,568 -16,696 -10,766 -1,256 117.29%
Tax 0 -500 -2,652 137 0 -
NP -28,059 -11,568 -14,044 -10,766 -1,256 117.29%
Tax Rate - - - - - -
Total Cost 28,498 14,085 15,857 11,925 1,256 118.13%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
NP Margin -6,391.57 -459.59 -774.63 -928.90 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
EPS -0.51 -0.25 -0.34 -0.26 -0.10 50.23%
EPS Diluted -0.51 -0.25 -0.34 -0.26 -0.10 50.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.